Leaddisc · Newsroom
LDC and HZI enter partnership for the discovery of new drugs against multi-resistant bacteria
The Lead Discovery Center GmbH (LDC) and the Helmholtz Centre for Infection Research (HZI) will be working in close cooperation to identify and optimize new drug candidates against methicillin-resistant Staphylococcus aureus (MRSA).April 1, 2015
LDC Receives 1 Million Euros from the Max Planck Foundation
The Lead Discovery Center receives one million euros from the Max Planck Foundation for the development of new drug candidates.March 10, 2015
LDC and The Arctic University of Norway Collaborate to Discover New Medicines from the Arctic Ocean
The Lead Discovery Center GmbH (LDC), a renowned translational research organization, and UiT The Arctic University of Norway (UiT) have teamed up to discover new medicines from the marine arctic environment.October 11, 2014
LDC Enters First Collaboration with the Helmholtz Association
New cancer therapy approach from the German Cancer Consortium (DKTK)October 9, 2014
LDC Forms Early Drug Discovery Alliance with Daiichi Sankyo
Utilizing shared compound libraries for novel LDC targetsApril 17, 2014
Hit Discovery Constance GmbH: a new European hub for HTS and compound management
Today Hit Discovery Constance GmbH (“HDC”), a new joint venture organisation between Lead Discovery Center (Dortmund/Germany), Centre for Drug Design and Discovery (CD3, KULeuven, Leuven/Belgium) and Axxam (Milan/Italy) has started its operation.January 15, 2014
Anti-Cancer Program Originating from LDC Reaches Clinical Trials
First LDC-lead structure successfully progressed by Bayer Pharma AG into clinical study phaseDecember 7, 2013
Lead Discovery Center GmbH Announces Five-year Strategic Partnership with Merck Serono
Partners will collaborate to discover lead structures and potential development candidates for novel drug targetsOctober 31, 2013